Alterity Therapeutics to Present at the MST Access Australian Micro & Small Caps Conference

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases, today announced that Dr David Stamler, Chief Executive Officer will present a company overview at the MST Access Australian Micro & Small Caps Conference on Thursday 17 June 2021 at 9:15 a.m. AEST / Wednesday 16th June at 4.15pm PDT.

To join the presentation, please click the webinar link below:                              

https://mstfinancial-au.zoom.us/j/89046912526https://mstfinancial-au.zoom.us/j/89046912526

END

Authorisation & Additional information

This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.